Explore By Subject Area   
Return Home
Menu

Lead Editorial

Editor's Pick: Operationalizing a New R&D Patient-Centricity Model at J&J

Editor's Pick: Operationalizing a New R&D Patient-Centricity Model at J&J

Gonzalo Linares, Global Head of Patient Advocacy, R&D at Johnson & Johnson, discusses the systematic and strategic approach to the way the company collaborates with patient organizations throughout the R&D process. This article originally ran in August 2025. 

Read More

Featured Editorial

Editor's Pick: How Pfizer Is Tackling Patient Insight Continuity Across a Global Organization

Read More

How Biogen Acts on Patient Feedback

Read More

Questex Presents the 10th Annual Patients as Partners® in Clinical Trials Europe Conference

Read More

What Patients and Sites Want, and Don't Want, from Tech in Clinical Trials, from Partnerships with Sites 2025

Read More

More Related Content

Editorial

How Sponsors Can Be Better Partners to Rural Sites Bringing Clinical Research to Patients

How Sponsors Can Be Better Partners to Rural Sites Bringing Clinical Research to Patients
Questex Announces the 2026 Patients as Partners® in Clinical Research Meeting with Keynotes and Topics

Questex Announces the 2026 Patients as Partners® in Clinical Research Meeting with Keynotes and Topics
What Does Clinical Trial Tokenization Mean for Real-World Data and Long-Term Patient Follow-Up?

What Does Clinical Trial Tokenization Mean for Real-World Data and Long-Term Patient Follow-Up?
How Agios Partnered with the Sickle Cell Community to Design the RISE UP Phase 2/3 Trial and Awareness Campaign

How Agios Partnered with the Sickle Cell Community to Design the RISE UP Phase 2/3 Trial and Awareness Campaign
Conference Forum Joins Fierce Life Sciences

Conference Forum Joins Fierce Life Sciences
How AbbVie Is Shifting the Focus from Decentralization to Patient & Site Centricity

How AbbVie Is Shifting the Focus from Decentralization to Patient & Site Centricity
Overcoming Reach and Recruitment Challenges to Engage Rare Disease Patients in Clinical Trials

Overcoming Reach and Recruitment Challenges to Engage Rare Disease Patients in Clinical Trials

Sponsored
How Boehringer Ingelheim’s Site Engagement Academy Is Helping to Create Empathetic Site Partnerships for Patient Benefit

How Boehringer Ingelheim’s Site Engagement Academy Is Helping to Create Empathetic Site Partnerships for Patient Benefit
Collaborating for Change: Integrating Clinical Trials into Care Pathways

Collaborating for Change: Integrating Clinical Trials into Care Pathways
Operationalizing a New R&D Patient-Centricity Model at J&J

Operationalizing a New R&D Patient-Centricity Model at J&J
Involving Patient Insights in Medicine Development to Better Support Access and Decision-Making: Patients as Partners Europe 2025 Recap

Involving Patient Insights in Medicine Development to Better Support Access and Decision-Making: Patients as Partners Europe 2025 Recap
How Pfizer Is Tackling Patient Insight Continuity Across a Global Organization

How Pfizer Is Tackling Patient Insight Continuity Across a Global Organization
7 Key Takeaways of the Novo Nordisk Rare Disease Survey in Sickle Cell Disease from Patients as Partners 2025

7 Key Takeaways of the Novo Nordisk Rare Disease Survey in Sickle Cell Disease from Patients as Partners 2025
The Role of the Chief Medical Officer In Championing Patient-Centric Drug Development

The Role of the Chief Medical Officer In Championing Patient-Centric Drug Development
CRO Perspective on Connecting Advocacy and Industry to Advance Patient-Centric Medicine

CRO Perspective on Connecting Advocacy and Industry to Advance Patient-Centric Medicine

Sponsored
How Patient Involvement Gets Done to Better Support Access, Decision-making and Medicine Development: Patients as Partners 2025 Recap

How Patient Involvement Gets Done to Better Support Access, Decision-making and Medicine Development: Patients as Partners 2025 Recap
What Clinical Research Means to Patients in Ukraine, and How Industry Sponsors Can Help

What Clinical Research Means to Patients in Ukraine, and How Industry Sponsors Can Help
Biogen on Digital Innovations to Increase Trial Access and Enhance Patient Experiences

Biogen on Digital Innovations to Increase Trial Access and Enhance Patient Experiences
Moderna on Building Its Patient Insights Framework from Scratch

Moderna on Building Its Patient Insights Framework from Scratch
Where Technology Is Reducing or Increasing Burden on the Clinical Trial Site Level

Where Technology Is Reducing or Increasing Burden on the Clinical Trial Site Level
Embedding Sustainable Patient Engagement in R&D: White Paper

Embedding Sustainable Patient Engagement in R&D: White Paper

Sponsored
Advancing Dementia Medicine Development Using Digital Health Tech Maturity and Patient-Centric Measures

Advancing Dementia Medicine Development Using Digital Health Tech Maturity and Patient-Centric Measures
Merck Takes on Global Digital Accessibility Policy for Patients and Employees

Merck Takes on Global Digital Accessibility Policy for Patients and Employees
Letter from the Conference Forum Editorial Directors

Letter from the Conference Forum Editorial Directors
Lundbeck on Incorporating Patient Insights Into Medicine Development in Brain Diseases

Lundbeck on Incorporating Patient Insights Into Medicine Development in Brain Diseases
The Conference Forum Sees Record Growth in Attendees Across 2024 Events, Bringing Together Leaders in Medicine Development

The Conference Forum Sees Record Growth in Attendees Across 2024 Events, Bringing Together Leaders in Medicine Development
What Patients Want from Clinical Trials, with a Multi-Time Clinical Trial Participant

What Patients Want from Clinical Trials, with a Multi-Time Clinical Trial Participant
From the Archive: How Merck Is Increasing the Representation of Diverse Patient Participants and Clinical Staff

From the Archive: How Merck Is Increasing the Representation of Diverse Patient Participants and Clinical Staff
Clinical Trial Participation Is Covered Under Family and Medical Leave Act, per US Department of Labor

Clinical Trial Participation Is Covered Under Family and Medical Leave Act, per US Department of Labor
How Pharma Can Be a Good Collaborator in Pediatric Cancer Research

How Pharma Can Be a Good Collaborator in Pediatric Cancer Research
Astellas’ Dr Anthony Yanni on Creating a Strong Patient-Centricity Model in Pharma

Astellas’ Dr Anthony Yanni on Creating a Strong Patient-Centricity Model in Pharma
How Clinical Research as a Care Option Gets Done in New York’s Largest, and Least Populated County

How Clinical Research as a Care Option Gets Done in New York’s Largest, and Least Populated County
From the Archive: How Genentech Designs Inclusive Clinical Trials to Reach More Patients

From the Archive: How Genentech Designs Inclusive Clinical Trials to Reach More Patients
Where Pharma Can Improve Patient Experience, with MRCT Center

Where Pharma Can Improve Patient Experience, with MRCT Center
How Can We Get Patients in Community Care Settings Access to Clinical Trials?

How Can We Get Patients in Community Care Settings Access to Clinical Trials?
The Nuts and Bolts of Bringing Clinical Research into Community Hospitals

The Nuts and Bolts of Bringing Clinical Research into Community Hospitals
AstraZeneca Human Factors Engineer Integrates the Patient Experience into Improving Drug Device User Experience

AstraZeneca Human Factors Engineer Integrates the Patient Experience into Improving Drug Device User Experience
AbbVie’s Director of Clinical Study Patient Platforms on Supporting Patients in Decentralized Trials

AbbVie’s Director of Clinical Study Patient Platforms on Supporting Patients in Decentralized Trials
Making Clinical Trials More Inclusive for Sex- and Gender-Diverse People

Making Clinical Trials More Inclusive for Sex- and Gender-Diverse People

Sponsored
BMS and the LGBTQ+ Community Improve Clinical Data to Achieve Health Equity

BMS and the LGBTQ+ Community Improve Clinical Data to Achieve Health Equity
From the Archive: How Sanofi’s Integration of the Patient Voice Impacted Recruitment, Protocols and Time to Market

From the Archive: How Sanofi’s Integration of the Patient Voice Impacted Recruitment, Protocols and Time to Market
The Evolution of Community Outreach and Engagement at National Cancer Institute‐Designated Cancer Centers

The Evolution of Community Outreach and Engagement at National Cancer Institute‐Designated Cancer Centers
How Quantitative Patient Preferences Are Helping Clinical and Regulatory Decision-Making

How Quantitative Patient Preferences Are Helping Clinical and Regulatory Decision-Making
​​​​​​​Demonstrating How Patient Engagement Gets Done: Patients as Partners in Clinical Research 2024 Recap

​​​​​​​Demonstrating How Patient Engagement Gets Done: Patients as Partners in Clinical Research 2024 Recap
How Regeneron Is Applying Innovation to Modernize Clinical Trials

How Regeneron Is Applying Innovation to Modernize Clinical Trials
When Immunotherapy Offers the Chance for Life and Family After Cancer Diagnosis

When Immunotherapy Offers the Chance for Life and Family After Cancer Diagnosis
Medical PTSD and What Clinical Trial Executives Should Know

Medical PTSD and What Clinical Trial Executives Should Know
AbbVie Goes Upstream for Greater Inclusivity in Clinical Trials

AbbVie Goes Upstream for Greater Inclusivity in Clinical Trials
The Patient Perspective: How to Create Real Investment in Diversifying Research Participation

The Patient Perspective: How to Create Real Investment in Diversifying Research Participation
Instilling a Broader Patient-Focused Mentality with Alexion’s VP of Global Patient Experience

Instilling a Broader Patient-Focused Mentality with Alexion’s VP of Global Patient Experience
Roche Moves from Patient-Centricity to Patient-Inclusivity: Inside and Outside the Company

Roche Moves from Patient-Centricity to Patient-Inclusivity: Inside and Outside the Company
Novartis’ Bold Vision to Change How the Entire Sector Engages Patients

Novartis’ Bold Vision to Change How the Entire Sector Engages Patients
How Pfizer Builds Patient Centricity Across the Entire Company

How Pfizer Builds Patient Centricity Across the Entire Company
Parexel’s First Patient Ambassador on Being a Voice for Patients

Parexel’s First Patient Ambassador on Being a Voice for Patients

Sponsored
Centering the Patient in Plasma-Based Therapy Development at Takeda

Centering the Patient in Plasma-Based Therapy Development at Takeda
Astellas Pharma on Next Steps for Patient Engagement in Pharma

Astellas Pharma on Next Steps for Patient Engagement in Pharma
Fenway Health Builds Community Trust to Bring Clinical Trials to Underserved Populations

Fenway Health Builds Community Trust to Bring Clinical Trials to Underserved Populations
Fox Chase Cancer Center Builds a Community Engagement Foundation for Trials

Fox Chase Cancer Center Builds a Community Engagement Foundation for Trials
The Rare Disease Patient Voice Created Endpoints with Impact

The Rare Disease Patient Voice Created Endpoints with Impact
How Boehringer Ingelheim Incorporates Patient Feedback in Trial Design

How Boehringer Ingelheim Incorporates Patient Feedback in Trial Design
Janssen R&D on Lessons Learned from Creating a Patient Data Portal

Janssen R&D on Lessons Learned from Creating a Patient Data Portal
Archive Highlight: Patient Advocacy's Power to Save Lives

Archive Highlight: Patient Advocacy's Power to Save Lives
Advice from a Customer Service Expert On Treating Patients like Partners

Advice from a Customer Service Expert On Treating Patients like Partners
The Patient Story on the Life-Saving Clinical Trial After a Stage IV Cancer Diagnosis

The Patient Story on the Life-Saving Clinical Trial After a Stage IV Cancer Diagnosis

Subscribe for More Information

Please provide your contact information and select areas of interest to receive updates.